In summary, GFDHP reduced mucus overproduction and attenuated pulmonary ventilation function in LPS/CS-induced COPD mice by suppressing Muc5ac and the ERK-SP1 signaling pathway. Here, MUC5AC is linked to chronic obstructive pulmonary disease.